ZBNA
TBPH icon

Zions Bancorporation, National Association’s Theravance Biopharma TBPH Stock Holding History

Zions Bancorporation, National Association’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255 Hold
15
– – ﹤0.01% 1592
2026
Q1 		$243 Buy
+15
New +$265 ﹤0.01% 1512

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Zions Bancorporation, National Association's TBPH Position: Q2 2026 in Review

Zions Bancorporation, National Association held its Theravance Biopharma (TBPH) position steady in Q2 2026 at 15 shares worth $255. The position accounts for ﹤0.01% of the portfolio, ranked #1592.

Zions Bancorporation, National Association first reported a position in TBPH in Q1 2026 and has held it in 2 quarters since. 180 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Zions Bancorporation, National Association held 15 shares of Theravance Biopharma worth $255 as of Q2 2026.
  • Zions Bancorporation, National Association left its Theravance Biopharma share count unchanged in Q2 2026.
  • Theravance Biopharma made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1592 holding.
  • Zions Bancorporation, National Association first reported a position in Theravance Biopharma in Q1 2026 and has held it in 2 quarters since.
  • 180 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.